Articles by Murray L. Barclay, MB ChB, MD

Use and Predictors of Oral Complementary and Alternative Medicine by Patients With Inflammatory Bowel Disease: A Population-Based, Case–Control Study

Koning, Marije; Ailabouni, Ramez; Gearry, Richard B.; More

Inflammatory Bowel Diseases. 19(4):767-778, March-April 2013.

Differential association of twoPTPN22coding variants with Crohn's disease and ulcerative colitis

Diaz-Gallo, Lina-Marcela; Espino-Paisán, Laura; Fransen, Karin; More

Inflammatory Bowel Diseases. 17(11):2287-2294, November 2011.

Association of the protein‐tyrosine phosphatase nonreceptor type substrate 1 (PTPNS1) gene with inflammatory bowel disease

Roberts, Rebecca L.; Hollis-Moffatt, Jade E.; Gómez-García, María; More

Inflammatory Bowel Diseases. 17(2):E19-E21, February 2011.

Effect of inflammatory bowel disease classification changes onNOD2genotype–phenotype associations in a population‐based cohort

Gearry, Richard B.; Roberts, Rebecca L.; Burt, Michael J.; More

Inflammatory Bowel Diseases. 13(10):1220-1227, October 2007.

Association ofDLG5variants with inflammatory bowel disease in the New Zealand caucasian population and meta‐analysis of the DLG5 R30Q variant

Browning, Brian L.; Huebner, Claudia; Petermann, Ivonne; More

Inflammatory Bowel Diseases. 13(9):1069-1076, September 2007.